Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

SHA:603079 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,832	3,316	2,281	2,486	2,148	2,962
Market Cap Growth	8.69%	45.41%	-8.28%	15.73%	-27.46%	-19.91%
Enterprise Value	2,586	3,068	2,298	2,343	1,896	2,598
Last Close Price	15.11	17.72	13.47	14.49	12.42	16.92
PE Ratio	51.54	53.36	77.51	-	68.24	39.09
Forward PE	-	55.60	55.60	55.60	55.60	55.60
PS Ratio	3.41	3.93	2.76	3.42	2.91	3.75
PB Ratio	1.74	2.05	1.78	1.96	1.60	2.22
P/TBV Ratio	2.07	2.46	2.23	2.46	1.96	2.57
P/OCF Ratio	18.06	23.88	15.42	38.60	52.76	39.77
EV/Sales Ratio	3.11	3.63	2.78	3.22	2.57	3.29
EV/EBITDA Ratio	19.28	21.53	21.75	133.26	32.90	19.77
EV/EBIT Ratio	45.05	45.75	72.85	-	-	42.95
Debt / Equity Ratio	0.21	0.20	0.21	0.19	0.03	0.13
Debt / EBITDA Ratio	2.50	2.26	2.47	13.19	0.73	1.28
Net Debt / Equity Ratio	-0.17	-0.20	-0.06	-0.07	-0.21	-0.27
Net Debt / EBITDA Ratio	-2.10	-2.28	-0.78	-4.98	-5.00	-2.78
Net Debt / FCF Ratio	-19.95	47.87	3.75	0.48	12.78	14.35
Asset Turnover	0.42	0.42	0.47	0.43	0.43	0.46
Inventory Turnover	2.95	3.28	3.12	2.51	2.44	2.94
Quick Ratio	3.59	3.28	1.94	1.51	1.58	1.62
Current Ratio	4.69	4.10	2.82	2.35	2.64	2.23
Return on Equity (ROE)	4.16%	4.78%	2.92%	-4.15%	2.27%	5.40%
Return on Assets (ROA)	1.79%	2.10%	1.13%	-2.02%	-0.37%	2.18%
Return on Invested Capital (ROIC)	3.74%	4.66%	2.01%	-4.87%	-0.83%	5.88%
Return on Capital Employed (ROCE)	2.90%	3.40%	2.10%	-3.80%	-0.70%	4.50%
Earnings Yield	1.89%	1.87%	1.29%	-2.17%	1.47%	2.56%
FCF Yield	0.49%	-0.21%	-0.96%	-7.30%	-1.05%	-0.86%
Dividend Yield	-	0.56%	-	0.41%	0.48%	0.83%
Payout Ratio	14.86%	12.57%	61.41%	-	87.12%	86.42%
Buyback Yield / Dilution	-9.40%	-2.60%	-2.45%	3.41%	-1.59%	-2.03%
Total Shareholder Return	-9.40%	-2.04%	-2.45%	3.82%	-1.11%	-1.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.